MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages

  Dettmer, Matthias ^a   Vogetseder, Alexander ^b   Durso, Mary Beth ^a   Moch, Holger ^b   Komminoth, Paul ^c   Perren, Aurel ^d   Nikiforov, Yuri E ^a   Nikiforova, Marina N ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TRIEMLI HOSPITAL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 125A 3P; MICRORNA 146B 3P; MICRORNA 146B 5P; MICRORNA 182; MICRORNA 183; MICRORNA 199A 3P; MICRORNA 199A 5P; MICRORNA 221; MICRORNA 222; MICRORNA 449A; MICRORNA 455 3P; MICRORNA 455 5P; MICRORNA 542 5P; MICRORNA 574 3P; MICRORNA 874; MICRORNA 885 5P; MICRORNA 96; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CLUSTER ANALYSIS; CONTROLLED STUDY; CONVENTIONAL THYROID FOLLICULAR CARCINOMA; DIAGNOSTIC ACCURACY; DOWN REGULATION; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC DIFFERENCE; GENETIC MARKER; HUMAN; HUMAN TISSUE; HYPERPLASTIC NODULE; MICROARRAY ANALYSIS; ONCOCYTIC THYROID FOLLICULAR CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; UPREGULATION;

ADENOCARCINOMA, FOLLICULAR; ALGORITHMS; BIOPSY, FINE-NEEDLE; CARCINOMA; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; OXYPHIL CELLS; PROGNOSIS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VALIDATION STUDIES AS TOPIC;

EID: 84872090864     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2694     Document Type: Article

References (46)

1. DeLellis R, Lloyd R, Heitz P, Eng C, eds. 2004 Pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press [World Health Organization classification of tumours]
2. Nikiforov YE 2012 Thyroid tumors: classification, staging and general considerations. In: Nikiforov Y, Biddinger, PW, Thompson, LDR, eds. Diagnostic pathology and molecular genetics of the thyroid. Baltimore: Lippincott Williams & Wilkins; 108-118
3. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN 2011 Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96:3390-3397
4. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098
5. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95:1365-1369
6. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn 2nd GW, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPAR γ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326
7. Sobrinho-Simoes M, Eloy C, Magalhaes J, Lobo C, Amaro T 2011 Follicular thyroid carcinoma. Mod Pathol 24(Suppl 2):S10-S18
8. Lynam-Lennon N, Maher SG, Reynolds JV 2009 The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84:55-71
9. Garzon R, Calin GA, Croce CM 2009 MicroRNAs in Cancer. Annu Rev Med 60:167-179
10. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V 2004 Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:R13
11. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM 2005 A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801
12. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC 2006 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198
13. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG 2009 MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69:5776-5783
14. Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G 2010 MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol 42:312-319
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR 2005 MicroRNA expression profiles classify human cancers. Nature 435:834-838
16. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE 2002 PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 26:1016-1023
17. Barbarotto E, Schmittgen TD, Calin GA 2008 MicroRNAs and cancer: profile, profile, profile. Int J Cancer 122:969-977
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM 2006 A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261
19. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM 2002 Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-15529
20. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102:19075-19080
21. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine Relat Cancer 13:497-508
22. Schwertheim S, Sheu SY, Worm K, Grabellus F, Schmid KW 2009 Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res 41:475-481
23. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE 2008 MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600-1608
24. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, Livolsi VA, Baloch ZW 2007 Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol 18:163-173
25. Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, Nikiforova MN 2011 MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18:2035-2041
26. Chen YT, Kitabayashi N, Zhou XK, Fahey 3rd TJ, Scognamiglio T 2008 MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139-1146
27. Nikiforova MN, Chiosea SI, Nikiforov YE 2009 MicroRNA expression profiles in thyroid tumors. Endocr Pathol 20:85-91
28. Menon MP, Khan A 2009 Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 62: 978-985
29. Chou CK, Chen RF, Chou FF, Chang HW, Chen YJ, Lee YF, Yang KD, Cheng JT, Huang CC, Liu RT 2010 miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid 20:489-494
30. Akama T, Sue M, Kawashima A, Wu H, Tanigawa K, Suzuki S, Hayashi M, Yoshihara A, Ishido Y, Ishii N, Suzuki K 2012 Identification of microRNAs that mediate thyroid cell growth induced by TSH. Mol Endocrinol 26:493-501
31. Leone V, D'Angelo D, Rubio I, de Freitas PM, Federico A, Colamaio M, Pallante P, Medeiros-Neto G, Fusco A 2011 MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1α. J Clin Endocrinol Metab 96:E1388-E1398
32. Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C 2006 A limited set of human microRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab 91:3584-3591
33. Nikiforova MN, Caudill CM, Biddinger P, Nikiforov YE 2002 Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol 10:15-22
34. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2[-ΔΔC(T)] method. Methods 25:402-408
35. Shirdel EA, Xie W, Mak TW, Jurisica I 2011 NAViGaTing the micronome-using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 6:e17429
36. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL, Morris Q, Bader GD 2010 GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 26:2927-2928
37. Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q 2010 The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214-W220
38. Sobrinho-Simões M, Preto A, Rocha AS, Castro P, Máximo V, Fonseca E, Soares P 2005 Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447:787-793
39. Fusco A, Viglietto G, Santoro M 2005 Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. Br J Cancer 92:1817-1818
40. Máximo V, Lima J, Soares P, Silva A, Bento I, Sobrinho- Simões M 2008 GRIM-19 in health and disease. Adv Anat Pathol 15:46-53
41. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, Facchiano F, Liuzzi F, Lulli V, Morsilli O, Santoro S, Valtieri M, Calin GA, Liu CG, Sorrentino A, Croce CM, Peschle C 2005 MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102:18081-18086
42. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, Leone V, Borbone E, Petrocca F, Alder H, Croce CM, Fusco A 2007 MicroRNAs(miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14:791-798
43. Sun T, Yang M, Kantoff P, Lee GS 2009 Role of microRNA-221/-222 in cancer development and progression. Cell Cycle 8:2315-2316
44. Hunt JL, Yim JH, Carty SE 2006 Fractional allelic loss of tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid tumors. Thyroid 16:643-649
45. Ma X, Kalakonda S, Srinivasula SM, Reddy SP, Platanias LC, Kalvakolanu DV 2007 GRIM-19 associates with the serine protease HtrA2 for promoting cell death. Oncogene 26:4842-4849
46. Máximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simões M 2005 Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. British journal of cancer 92:1892-1898